Bukwang Pharm (003000) — Cash Flow Quality Index
Bukwang Pharm (003000) has a Cash Flow Quality Index of -4.08x as of September 2025. Operating cash flow of ₩-6.24 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 003000 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bukwang Pharm Cash Flow Quality Index (2007–2018)
Historical Cash Flow Quality Index for Bukwang Pharm across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 003000 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bukwang Pharm (2007–2018)
Year-by-year earnings quality comparison for Bukwang Pharm. For live market cap and the full company financial profile, see 003000 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 0.05x | ₩6.82 Billion | ₩145.67 Billion | ▼ -93.9% |
| 2017 | 0.77x | ₩8.56 Billion | ₩11.09 Billion | ▲ +257.2% |
| 2016 | -0.49x | ₩-7.76 Billion | ₩15.81 Billion | ▼ -219.9% |
| 2015 | 0.41x | ₩10.30 Billion | ₩25.14 Billion | ▼ -65.3% |
| 2014 | 1.18x | ₩27.86 Billion | ₩23.62 Billion | ▼ -36.9% |
| 2013 | 1.87x | ₩36.52 Billion | ₩19.53 Billion | ▲ +120.1% |
| 2007 | 0.85x | ₩27.87 Billion | ₩32.82 Billion | — |